Global X China Biotech ETF (02820.HK) Rises 3.85% in Afternoon Trade, AUM at HKD 607 Million
NewTimeSpace News: As of 14:56 on July 3, Global X China Biotech ETF (02820.HK) traded at HKD 67.900, up 3.85%. The ETF opened at HKD 67.040, reached a high of HKD 67.900 and a low of HKD 66.000, with intraday volatility of 2.91%. Volume stood at 36,800 shares, with turnover of approximately HKD 2.4575 Million and an average price of HKD 66.797. The turnover rate was 0.40%. Net Asset Value (NAV) stood at HKD 65.909, with a discount rate of 0.80%. Total issued shares were 9.20 Million, with Assets Under Management (AUM) totaling approximately HKD 607 Million.
Global X China Biotech ETF (02820.HK) tracks the Solactive China Biotech Index NTR (Net Total Return). The constituent stocks of the index are highly concentrated in leading enterprises and boast distinctive innovative characteristics.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- HK shares ETFs Daily Report: Biotech Themes Lead as STAR 50 and ChiNext Pull Back - September 17, 2026
- HK shares ETFs Daily Report: Biotech Surges to Lead as Hong Kong New Listings Plunge and Korea/Semiconductor Themes Retreat Sharply — September 14, 2026
- Global X China Biotech ETF (02820.HK) Falls 1.10% in Afternoon Trade, Turnover at HKD 1.2817 Million
- Global X China Biotech ETF (02820.HK) Falls 3.30% in Afternoon Trade, AUM at HKD 695 Million
- HK shares ETFs Daily Report: Biomedicine Rebounds Across the Board! Gold Miners and Leveraged ChiNext Under Pressure and Pull Back - 20260825